Brief: Ovid Therapeutics Posts Q2 Loss Per Share $0.21

Ovid Therapeutics

09/08/2022 14:52

Aug 9 (Reuters) - Ovid Therapeutics Inc  OVID.O :
    * OVID THERAPEUTICS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
AND CORPORATE HIGHLIGHTS
    * Q2 LOSS PER SHARE $0.21
    * ENDED Q2 2022 WITH CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES OF $152.4 MILLION
    * CASH EXPECTED TO SUPPORT ADVANCEMENT OF ITS EPILEPSY
PIPELINE
INTO 2025
    * Q2 EARNINGS PER SHARE VIEW $-0.25 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX49svRR 
Further company coverage:  OVID.O 

 ((reuters.briefs@thomsonreuters.com;))